Evaluation Effect of Tenofovir Alafenamide (TAF) in Long-Term Therapy for Chronic Hepatitis B: A Systematic Review
Background: Tenofovir alafenamide (TAF) is phosphonamidate prodrug of tenofir that inhibits hepatitis B virus and HIV type-1 reverse transcription. TAF more stable form in plasma than tenofovir disoproxil fumarate (TDF) as choice treatment before. TAF in long-term treatment also significantly reduce...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2022-12-01
|
Series: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
Subjects: | |
Online Access: | https://www.ina-jghe.com/index.php/jghe/article/view/856 |